tiprankstipranks

Kevin Lofton Insider Profile

4 Followers
Kevin Lofton, Director at Gilead Sciences, holds 92.65K shares in Gilead Sciences (Ticker: GILD), holds 4.19K shares in Medtronic (Ticker: MDT), holds 46.19K shares in Rite Aid (Ticker: RADCQ).
tipranks
Kevin Lofton

Kevin Lofton
Gilead Sciences (GILD)
Director

Ranked #19,424 out of 98,564 Corporate Insiders

Profitable Transactions

67%
4 out of 6 Profitable Transactions

Average Return

+12.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$7M
94.72%
5.20%
0.08%
A breakdown of Kevin Lofton's holdings

Insider Roles

Gilead Sciences
(GILD)
Director
Medtronic
(MDT)
Director
Rite Aid
(RADCQ)
Director
Roles that Kevin Lofton holds in companies

Most Profitable Insider Trade

Stock:
Gilead Sciences
(GILD)
Rating:Informative Buy
Date:Apr 29, 2022 - Apr 29, 2023
Return:+44.40%
The most profitable trade made by Kevin Lofton

Kevin Lofton's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Gilead Sciences
May 04, 2023
Director
Uninformative Buy
$6.21M
Medtronic
May 03, 2023
Director
Uninformative Buy
175.01K
$340.69K
Rite Aid
Jul 09, 2021
Director
Uninformative Buy
$5.54K
List of latest transactions for each holding click on a transaction to see Kevin Lofton's performance on stock

Kevin Lofton insider profile FAQ

What is the percentage of profitable transactions made by Kevin Lofton?
The percentage of profitable transactions made by Kevin Lofton is 67%.
    What is the average return per transaction made by Kevin Lofton?
    The average return per transaction made by Kevin Lofton is 12.50%.
      What stocks does Kevin Lofton hold?
      Kevin Lofton holds: GILD, MDT, RADCQ stocks.
        What was Kevin Lofton’s latest transaction?
        Kevin Lofton latest transaction was an Uninformative Buy of ―.
          What was Kevin Lofton's most profitable transaction?
          Kevin Lofton’s most profitable transaction was an Informative Buy of GILD stock on April 29, 2022. The return on the trade was 44.40%.
            What is Kevin Lofton's role in Gilead Sciences?
            Kevin Lofton's role in Gilead Sciences is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.